- Patient's Testimonial
A patient was 66 years old when he was diagnosed with Descending Colon cancer by the doctors in Dec.2009.
The patient started Dendritic Cell Therapy on the recommendation of doctors. The six doses were administered from 2/4/11 to 29/06/11 in the presence of Doctors.
A female patient was diagnosed with Sigmoid Colon Caner with liver Mets at the age of 42 in 2010. In due course of time she had gone very weak and her condition was deteriorating. She was given Chemotherapy twice, which deteriorated her condition further because of the complications of chemotherapy.
1. What are Dendritic cells, and why are they useful?
Dendritic cells are in every person?s bloodstream. Their usual function is to identify a foreign substance, including cancer cells, and process the bits of such foreign substances and then jumpstart the immune response by bringing the foreign substance to the attention of the rest of the immune system (mostly T lymphocyte cells). The activated immune system is then able to circulate throughout the body and destroy the cancer cells.
2. What kind of cancers can be treated with Dendritic Cell therapy?
Theoretically all cancers can be treated, by Dendritic cells. To date, therapeutic benefit has been documented in B cell lymphoma, myeloma, melanoma, head and neck, prostate cancer, colon cancer, ovarian cancer, breast cancer, and renal cell cancer amongst others.
3. At what cancer stage should a patient consider Dendritic Cell therapy?
The patient can consider Dendritic cell therapy at any stage of the cancer.
4. How effective is Dendritic Cell therapy in cancer?
Responses have generally been promising as it is an autologous process; It does not have side effects, reduces cancer morbidity and improves the quality of life. Depending on the type of cancer and the functional status of patients the response may differ from patient to patient
5. Are any drugs or procedures used as part of the Dendritic Cell Therapy?
Few ingredients are added like cytokines such as recombinant human Il 4 recombinant human GMC SF and antibiotics to process the preparation of the Formulation.
6. Is Dendritic Cell Therapy safe?
Multiple early phases of Dendritic Cell therapy for cancer have been completed and establish the treatment as generally safe.
7. Are there any contraindications to Dendritic Cell Therapy?
Immunologic testing can better establish the condition of the immune system to help physicians determine if a patient is a good candidate for Dendritic Cell therapy. Active autoimmune disease as well as pregnancy is possible contraindications. Contradictions should be carefully discussed and reviewed with the consulting physician before proceeding.